New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...

据生物医药行业媒体Endpoints News梳理，生物技术公司Metsera和Terns Pharmaceuticals等都在布局每月给药1次的减肥药，但尚未达到公布Ⅱ期临床试验的阶段。诺和诺德也一直在研究每月一次的GLP-1/ ...

Federal and state health officials said Friday they are working to track down more information about a Salmonella outbreak ...

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, ...

COMMENT: Weight-loss jabs have become so normalised in adult life, it won’t be long before children are pestering their ...

Here are the top industries and stocks that were impacted by the comments, actions and policies of President-elect Trump this week compiled by ...

Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

The University of Pittsburgh Medical Center (UPMC) indicated increased medical utilization and rising pharmacy costs as reasons for its $371 million operating loss for the first nine months of the ...

Ozempic and other GLP-1 agonist medications have risen in popularity over the last few years due to their touted blood sugar management and weight-loss effects. However, some supp ...

BellRing Brands drives growth with strategic initiatives and high margins. Find out why BRBR stock is a solid buy despite its ...

For those using these products for weight loss only, it’s important to understand that these are not miracle drugs.